Potential First-in-Class Schizophrenia Drug Cuts Negative Symptoms Potential First-in-Class Schizophrenia Drug Cuts Negative Symptoms

SEP-363856, a novel antipsychotic with a distinct mechanism of action, reduces negative symptoms in schizophrenia, a new phase 2 trial suggests.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Psychiatry News Source Type: news